Is Aveo a good stock to buy?
AVEO Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
What counts as Insider trading?
Insider trading is the trading of a company's securities by individuals with access to confidential or material non-public information about the company. Taking advantage of this privileged access is considered a breach of the individual's fiduciary duty.
Can you go to jail for insider trading?
Criminal Penalties. The maximum prison sentence for an insider trading violation is now 20 years. The maximum criminal fine for individuals is now $5,000,000, and the maximum fine for non-natural persons (such as an entity whose securities are publicly traded) is now $25,000,000. Civil Sanctions.
Who are the victims of insider trading?
The victims are all those who sold Raj a stock or other security at a lower price than they might have if they had the same information he had. In other words, the victims are pensioners, mutual fund investors, bank trusts holders, and on.
The Last 12 Months Of Insider Transactions At AVEO Pharmaceuticals
Insiders at AVEO Pharmaceuticals Have Bought Stock Recently
The CEO, President & Director Michael Bailey made the biggest insider purchase in the last 12 months. That single transaction was for US$97k worth of shares at a price of US$6.48 each. That implies that an insider found the current price of US$6.64 per share to be enticing.
Does AVEO Pharmaceuticals Boast High Insider Ownership?
Over the last three months, we've seen significant insider buying at AVEO Pharmaceuticals. Not only was there no selling that we can see, but they collectively bought US$112k worth of shares. That shows some optimism about the company's future.
So What Does This Data Suggest About AVEO Pharmaceuticals Insiders?
For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our information indicates that AVEO Pharmaceuticals insiders own about US$535k worth of shares.
About AVEO Pharmaceuticals
It's certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious.
Golden Star Signal
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for patients with cancer and related diseases.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!